Sunday 18 October 2026
Export DYNTQ’s income statement to Excel — free account
Dynatronics Corporation
DYNTQ Healthcare Medical Devices
Dynatronics Corporation’s revenue for fiscal 2025 (year ended June 2025) was $27.4 million, down 15.8% from fiscal 2024. In the quarter to September 2025, revenue fell 7.61%, EPS grew 66.7% and free cash flow fell 193.0%, each against the same quarter a year earlier.
0.00
0.00
NaN
Follow DYNTQ
| Sep '25 | Jun '25 | Mar '25 | Dec '24 | Older periods | |
|---|---|---|---|---|---|
Piotroski F-Score |
3 | 3 | 6 | 5 |
+8 more TTM periods Free account |
| (2,563.17%) | (1,588.36%) | (64.70%) | (50.72%) | ||
| (57.18%) | (56.08%) | (13.78%) | (11.60%) | ||
ROIC |
(24.36%) | (25.59%) | (10.20%) | (8.10%) | |
Return on Tangible Assets |
(573.14%) | (519.88%) | (125.60%) | (88.58%) | |
Average Days of Receivables |
37.82 | 39.80 | 38.72 | 36.95 | |
Free Cash Flow per Share |
0.01 | 0.03 | 0.05 | (0.01) | |
Free Cash Flow |
0.08 | 0.27 | 0.42 | (0.07) | |
Capital Expenditures |
(0.03) | (0.03) | (0.04) | (0.22) | |
| Other line items | |||||
Cash ROIC |
1.01% | 3.97% | 2.73% | (0.41%) | |
Accounts Receivable Turnover |
8.45 | 7.96 | 7.89 | 8.26 | |
Accounts Payable Turnover |
7.13 | 6.99 | 6.06 | 6.13 | |
Inventory Turnover |
4.09 | 4.01 | 3.78 | 3.43 | |
Average Days of Payables |
54.92 | 58.11 | 61.34 | 55.44 | |
Days of Inventory on Hand |
83.64 | 86.62 | 90.64 | 104.67 | |
Tax Rate |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
30.03% | 30.90% | 31.08% | 30.68% | |
Share Based Compensation of Revenue |
0.01% | 0.01% | 0.02% | (0.04%) | |
Interest Coverage |
(5.63) | (5.99) | (5.65) | (4.63) | |
Operating CF/Net income |
(0.01) | (0.03) | (0.13) | (0.05) | |
Depreciation/Fixed assets |
5.67 | 5.33 | 0.62 | 0.63 | |
Capex/Depreciation |
0.00 | 0.00 | (0.04) | (0.20) | |
Revenue per Share |
2.06 | 3.37 | 3.23 | 4.13 | |
Operating CF per Share |
0.01 | 0.04 | 0.05 | 0.02 | |
Capex per Share |
0.00 | 0.00 | 0.00 | (0.03) | |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.01 |
Columns are period end dates